Perinatal immune changes to identify patients at risk of postpartum preeclampsia
- PMID: 40571428
- DOI: 10.1093/ajh/hpaf122
Perinatal immune changes to identify patients at risk of postpartum preeclampsia
Abstract
Background: Postpartum preeclampsia (PPPE) is a maternal condition characterized by de novo hypertension in the postpartum period with end-organ damage. We investigated the use of perinatal immune changes, through routine complete blood count (CBC), to identify high-risk individuals before PPPE development.
Methods: We performed a retrospective matched case-control study of 100 individuals with PPPE, 200 term pregnancies (Ctrl) and 200 antenatal preeclampsia (PE). Detailed demographic, obstetrical and laboratory data were retrieved from medical records. Statistical analysis was performed using one-way ANOVA, multivariate regression, and paired or unpaired t-tests, as appropriate.
Results: Individuals that developed PPPE were significantly older and predominantly Black vs Ctrl and PE. Both PE and PPPE had higher pre-pregnancy BMI and increased personal and family history of hypertension/PE vs Ctrl (p<0.001). Before delivery, individuals that later developed PPPE, had lower total leukocyte counts vs Ctrl (9.61 vs 10.75x109/L, p<0.05) whereas monocytes percentage were elevated (8.07 vs 7.27%, p<0.01). Comparing the postpartum/antenatal ratio in-between each condition revealed elevated leukocyte ratio in PPPE vs Ctrl (p<0.001). Neutrophils ratio was also increased whereas lymphocytes and monocytes were decreased in PPPE vs both Ctrl and PE. After adjusting for race, maternal age, pre-pregnancy BMI, personal history of PE/HT, and diabetes mellitus, perinatal immune changes were still significantly associated with PPPE.
Conclusions: Globally, perinatal immune changes were observed in individuals with a seemingly uncomplicated pregnancy prior to development of PPPE. This strongly supports that such changes could be used to identify high-risk individuals prior to disease onset.
Keywords: Postpartum preeclampsia; complete blood count; de novo hypertension; leukocytes; perinatal immune changes; women’s health.
© The Author(s) 2025. Published by Oxford University Press on behalf of American Journal of Hypertension, Ltd. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Similar articles
-
Epidural therapy for the treatment of severe pre-eclampsia in non labouring women.Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD009540. doi: 10.1002/14651858.CD009540.pub2. Cochrane Database Syst Rev. 2017. PMID: 29181841 Free PMC article.
-
Amnioinfusion for chorioamnionitis.Cochrane Database Syst Rev. 2016 Aug 24;2016(8):CD011622. doi: 10.1002/14651858.CD011622.pub2. Cochrane Database Syst Rev. 2016. PMID: 27556818 Free PMC article.
-
Maternal and neonatal outcomes of elective induction of labor.Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Evid Rep Technol Assess (Full Rep). 2009. PMID: 19408970 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
LinkOut - more resources
Full Text Sources